West African assay results propelled shares of a gold explorer sharply higher Monday. Here’s some small stocks making big moves on Monday, May 4, 2020 (as of 4 pm EST):
Roscan Gold Corporation (TSXV:ROS) shares climbed 40% to $0.365 on Monday after the gold explorer announced drill results from an additional four holes totaling 771 metres at its Mankouke South Target in Mali, which included 4.84 grams per tonne (g/t) gold over 62.0 metres.
As well, shares of Antibe Therapeutics Inc. (TSXV:ATE) slipped 10% to $0.64 as the biotechnology company said ongoing hospital restrictions, clinic closures and complexities arising from remote working constraints have slowed Veristat’s data collection, validation and analysis, which will delay top-line results for the Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346 that targets chronic pain and inflammation.
StageZero Life Sciences, Ltd. (TSX:SZLS), meanwhile, reported that it has entered into an enhanced relationship with Phleb-Finders, which is expected to introduce StageZero and its COVID-19 testing to Phleb-Finders’ broad network. StageZero Life Sciences stock moved up 12% to $0.145 following the announcement.
Finally, Balmoral Resources Ltd. (TSX:BAR) shares continued to move higher Monday, up 19% to $0.62 following a 5% gain on Friday, after the gold junior announced a new gold discovery on its Fenelon Property in Quebec, with drill results that included 2.97 metres grading 307.89 g/t gold.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.